Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 7;14(6):873-881.
doi: 10.2215/CJN.07950718. Epub 2019 May 2.

Postdialysis Hypokalemia and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis

Affiliations

Postdialysis Hypokalemia and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis

Tsuyoshi Ohnishi et al. Clin J Am Soc Nephrol. .

Abstract

Background and objectives: Almost half of patients on dialysis demonstrate a postdialysis serum potassium ≤3.5 mEq/L. We aimed to examine the relationship between postdialysis potassium levels and all-cause mortality.

Design, setting, patients, & measurements: We conducted a cohort study of 3967 participants on maintenance hemodialysis from the Dialysis Outcomes and Practice Patterns Study in Japan (2009-2012 and 2012-2015). Postdialysis serum potassium was measured repeatedly at 4-month intervals and used as a time-varying variable. We estimated the hazard ratio of all-cause mortality rate using Cox hazard regression models, with and without adjusting for time-varying predialysis serum potassium. Models were adjusted for baseline characteristics and time-varying laboratory parameters. We also analyzed associations of combinations of pre- and postdialysis potassium with mortality.

Results: The age of participants at baseline was 65±12 years (mean±SD), 2552 (64%) were men, and 96% were treated with a dialysate potassium level of 2.0 to <2.5 mEq/L. The median follow-up period was 2.6 (interquartile range, 1.3-2.8) years. During the follow-up period, 562 (14%) of 3967 participants died, and the overall mortality rate was 6.7 per 100 person-years. Compared with postdialysis potassium of 3.0 to <3.5 mEq/L, the hazard ratios of postdialysis hypokalemia (<3.0 mEq/L) were 1.84 (95% confidence interval, 1.44 to 2.34) in the unadjusted model, 1.44 (95% confidence interval, 1.14 to 1.82) in the model without adjusting for predialysis serum potassium, and 1.10 (95% confidence interval, 0.84 to 1.44) in the model adjusted for predialysis serum potassium. The combination of pre- and postdialysis hypokalemia was associated with the highest mortality risk (hazard ratio, 1.72; 95% confidence interval, 1.35 to 2.19, reference; pre- and postdialysis nonhypokalemia).

Conclusions: Postdialysis hypokalemia was associated with mortality, but this association was not independent of predialysis potassium.

Keywords: Confidence Intervals; Dialysis Solutions; Follow-Up Studies; Japan-Dialysis Outcomes and Practice Patterns Study; Potassium; Proportional Hazards Models; chronic hemodialysis; electrolytes; end-stage renal disease; hypokalemia; mortality; post-dialysis; renal dialysis; serum potassium.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Flowchart of eligible and ineligible participants. The numbers of potential and eligible patients in each phase are shown on the left side. The reasons for ineligibility and the number of ineligible participants are shown on the right side.
Figure 2.
Figure 2.
Cumulative survival was lowest in the low postdialysis K group, and other three group showed the similar cumulative survival. The definition of each groups is as follows: low, baseline postdialysis K<3.0mEq/L; medium-low, baseline postdialysis K≥3.0 to 3.5mEq/L; medium-high, postdialysis K≥3.5 to 4.0 mEq/L; high, postdialysis K≥4.0 mEq/L.
Figure 3.
Figure 3.
Hazard ratio increased depending on severity of hypokalemia, but the association was not statistically significant (95% confidence interval included 1.0). The thick black line shows the HR of all-cause mortality. The reference (HR=1) is 3.5 mEq/L. The gray area shows the 95% CI. The model was adjusted for baseline confounders of sex, age, body mass index, comorbidities, and medications, and time-varying confounders of serum albumin, C-reactive protein, normalized protein catabolic rate, dialysis vintage, single-pool Kt/V, dialysate bicarbonate, type of vascular access, and predialysis K.
Figure 4.
Figure 4.
The pattern of association of postdialysis hypokalemia with mortality different by baseline predialysis potassium level, but this effect modification was not statistically significant (interaction P=0.09). The numbers of patients in the high, medium, and low predialysis K groups were 790, 1892, and 1280, respectively. Five patients were excluded from this analysis because their predialysis K level was missing. The reference (HR=1) was 3.5mEq/L. The definition of subgroups is as follows: low, <4.5 mEq/L; medium, 4.5 to <5.5 mEq/L; and high, ≥5.5 mEq/L.

References

    1. United States Renal Data System : 2017 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2017
    1. Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, Kopple JD, Kalantar-Zadeh K: Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2: 999–1007, 2007 - PubMed
    1. Yusuf AA, Hu Y, Singh B, Menoyo JA, Wetmore JB: Serum potassium levels and mortality in hemodialysis patients: A retrospective cohort study. Am J Nephrol 44: 179–186, 2016 - PubMed
    1. Hwang JC, Wang CT, Chen CA, Chen HC: Hypokalemia is associated with increased mortality rate in chronic hemodialysis patients. Blood Purif 32: 254–261, 2011 - PubMed
    1. Lee S, Kang E, Yoo KD, Choi Y, Kim DK, Joo KW, Yang SH, Kim YL, Kang SW, Yang CW, Kim NH, Kim YS, Lee H: Lower serum potassium associated with increased mortality in dialysis patients: A nationwide prospective observational cohort study in Korea. PLoS One 12: e0171842, 2017 - PMC - PubMed

Publication types